Systems Pharmacology

PharmSci 360 connects experimental, computational and clinical evidence across drug discovery, development and delivery. Researchers will examine in-vitro-to-human translation using PBPK, quantitative systems pharmacology and AI; organ-chip and other human-relevant models; biomarkers and reliable bioanalytical assays; and integrating clinical trials with real-world data. Manufacturing sessions connect process understanding, analytical characterization and digital models with quality and scale-up. Formulation sessions address predictive design, advanced materials, targeted delivery and patient usability, alongside career development. Programme participants include Julie L. Gerberding (Foundation for the National Institutes of Health (FNIH)); Stephanie Barrett (Merck & Co., Inc.); Ben Boyd (Monash Institute of Pharmaceutical Sciences); Stephan Schmidt (University of Florida); Douglas Kiehl (Purdue University); Samir Mitragotri (Harvard University); Eric Appel (Stanford University). The American Association of Pharmaceutical Scientists hosts this in-person meeting at the Ernest N. Morial Convention Center, New Orleans, on 25–28 October 2026. The opening plenary is 25 October, 17:00–18:30; principal scientific symposia start at 09:00 on 26–28 October. The closing plenary is 28 October, 16:15–17:30, followed by a reception until 18:30. Times are America/Chicago, CDT (UTC−05:00). Current full-conference fees are US$1,705 for members, US$2,145 for non-members and US$325 for student/postdoc members; one-day passes are available. Registration requires an AAPS portal account. Use the official registration page linked from the event website. Ordinary cancellation refunds are no longer available.

PharmSci 360 connects experimental, computational and clinical evidence across drug discovery, development and delivery. Researchers will examine in-vitro-to-human translation using PBPK, quantitative systems pharmacology and AI; organ-chip and other human-relevant models; biomarkers and reliable bioanalytical assays; and integrating clinical trials with real-world data. Manufacturing sessions connect process understanding, analytical characterization and digital models with quality and scale-up. Formulation sessions address predictive design, advanced materials, targeted delivery and patient usability, alongside career development. Programme participants include Julie L. Gerberding (Foundation for the National Institutes of Health (FNIH)); Stephanie Barrett (Merck & Co., Inc.); Ben Boyd (Monash Institute of Pharmaceutical Sciences); Stephan Schmidt (University of Florida); Douglas Kiehl (Purdue University); Samir Mitragotri (Harvard University); Eric Appel (Stanford University). The American Association of Pharmaceutical Scientists hosts this in-person meeting at the Ernest N. Morial Convention Center, New Orleans, on 25–28 October 2026. The opening plenary is 25 October, 17:00–18:30; principal scientific symposia start at 09:00 on 26–28 October. The closing plenary is 28 October, 16:15–17:30, followed by a reception until 18:30. Times are America/Chicago, CDT (UTC−05:00). Current full-conference fees are US$1,705 for members, US$2,145 for non-members and US$325 for student/postdoc members; one-day passes are available. Registration requires an AAPS portal account. Use the official registration page linked from the event website. Ordinary cancellation refunds are no longer available.